Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
February 22, 2019
Nail disease, including ingrown nails, onychomycosis and nail malnutrition, is difficult to treat clinically, causing great problems for patients and doctors. Due to the slow growth of nails, it is difficult for external medicine to enter the nail bed through the deck, which makes the treatment of many nail diseases long, the patient compliance is poor, and the disease recurrence rate is high. In recent years, a variety of lasers, such as CO2 laser, Nd:YAG laser, diode laser, CO2 dot matrix laser, etc., have been widely used in the treatment of common nail diseases such as ingrown toxin, onychomycosis and nail dystrophy. CO2 laser can quickly destroy local tissue, remove hypertrophic hyperthyroidism, and instantly coagulate small blood vessels, achieving good results in the treatment of incisor. Nd:YAG laser, CO2 dot matrix laser and diode laser provide a new treatment option for onychomycosis. The micro-treatment area formed by CO2 dot laser can significantly enhance the penetration and absorption of topical drugs in the nail, which also shows a positive effect in the treatment of nail dystrophy.
The above is the laser treatment of nail disease we have listed for you. You can submit the following form to obtain more industry information we provide for you.
You can visit our website or contact us, and we will provide the latest consultation and solutions
Send Inquiry
Most Popular
lastest New
Send Inquiry
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.